The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of ofatumumab (OFA) maintenance treatment in relapsed chronic lymphocytic leukemia (CLL): Final analysis of PROLONG study.
 
Marinus Van Oers
Expert Testimony - Roche
 
Lukas Smolej
Honoraria - Abbvie; Gilead Sciences; Janssen; Roche
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen; Roche
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Janssen; Roche
 
Mario Petrini
Consulting or Advisory Role - Gilead Sciences; MSD; Novartis; Roche
Research Funding - Gilead Sciences; MSD; Novartis; Roche
Expert Testimony - Gilead Sciences; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Gilead Sciences; MSD; Novartis; Roche
 
Fritz Offner
No Relationships to Disclose
 
Sebastian Grosicki
No Relationships to Disclose
 
Mark-David Levin
Honoraria - Abbvie; Celgene; Janssen
Consulting or Advisory Role - Abbvie; Celgene; Janssen
Travel, Accommodations, Expenses - Celgene; Janssen; Roche
 
Jaclyn Davis
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Tommaso Stefanelli
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Hiya Banerjee
Employment - Merck (I); Novartis
Stock and Other Ownership Interests - Novartis
 
Petra Hoever
Employment - Novartis; Novartis (I)
Stock and Other Ownership Interests - Novartis; Novartis (I)
 
Christian Geisler
Consulting or Advisory Role - Janssen; Novartis